Overview

Clinical Trial to Evaluate the Safety and Efficacy of NTCB01-1 in Patients Who Require Parenteral Nutrition

Status:
COMPLETED
Trial end date:
2025-03-28
Target enrollment:
Participant gender:
Summary
A Randomized, Open-labeled, Multi-center, Active-controlled, Parallel-group Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of NTCB01-1 versus NTCB-P in patients who require parenteral nutrition
Phase:
PHASE3
Details
Lead Sponsor:
Yuhan Corporation